126
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      DNA interrogation by the CRISPR RNA-guided endonuclease Cas9

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The CRISPR-associated enzyme Cas9 is an RNA-guided endonuclease that uses RNA:DNA base-pairing to target foreign DNA in bacteria. Cas9:guide RNA complexes are also effective genome engineering agents in animals and plants. Here we use single-molecule and bulk biochemical experiments to determine how Cas9:RNA interrogates DNA to find specific cleavage sites. We show that both binding and cleavage of DNA by Cas9:RNA require recognition of a short trinucleotide protospacer adjacent motif (PAM). Non-target DNA binding affinity scales with PAM density, and sequences fully complementary to the guide RNA but lacking a nearby PAM are ignored by Cas9:RNA. DNA strand separation and RNA:DNA heteroduplex formation initiate at the PAM and proceed directionally towards the distal end of the target sequence. Furthermore, PAM interactions trigger Cas9 catalytic activity. These results reveal how Cas9 employs PAM recognition to quickly identify potential target sites while scanning large DNA molecules, and to regulate dsDNA scission.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Efficient In Vivo Genome Editing Using RNA-Guided Nucleases

          Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems have evolved in bacteria and archaea as a defense mechanism to silence foreign nucleic acids of viruses and plasmids. Recent work has shown that bacterial type II CRISPR systems can be adapted to create guide RNAs (gRNAs) capable of directing site-specific DNA cleavage by the Cas9 nuclease in vitro. Here we show that this system can function in vivo to induce targeted genetic modifications in zebrafish embryos with efficiencies comparable to those obtained using ZFNs and TALENs for the same genes. RNA-guided nucleases robustly enabled genome editing at 9 of 11 different sites tested, including two for which TALENs previously failed to induce alterations. These results demonstrate that programmable CRISPR/Cas systems provide a simple, rapid, and highly scalable method for altering genes in vivo, opening the door to using RNA-guided nucleases for genome editing in a wide range of organisms.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CRISPR RNA-guided activation of endogenous human genes

              Catalytically inactive CRISPR-associated 9 nuclease (dCas9) can be directed by short guide RNAs (gRNAs) to repress endogenous genes in bacteria and human cells. Here we show that a dCas9-VP64 transcriptional activation domain fusion protein can be directed by single or multiple gRNAs to increase expression of specific endogenous human genes. These results provide an important proof-of-principle that CRISPR-Cas systems can be used to target heterologous effector domains in human cells.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                14 February 2014
                29 January 2014
                6 March 2014
                06 September 2014
                : 507
                : 7490
                : 62-67
                Affiliations
                [1 ]Department of Chemistry, University of California, Berkeley, California, USA.
                [2 ]Department of Chemistry, Columbia University, New York, New York, USA.
                [3 ]Howard Hughes Medical Institute, University of California, Berkeley, California, USA.
                [4 ]Department of Biochemistry and Molecular Biophysics and Howard Hughes Medical Institute, Columbia University, New York, New York, USA.
                [5 ]Department of Molecular and Cell Biology, University of California, Berkeley, California, USA.
                [6 ]Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
                Author notes
                Reprints and permissions information are available at www.nature.com/reprints. J.A.D. is an inventor on a related patent. Correspondence and requests for materials should be addressed to J.A.D. ( doudna@ 123456berkeley.edu ) or E.C.G. ( ecg2108@ 123456columbia.edu ).
                [*]

                These authors contributed equally to this work.

                [†]

                Present address: Department of Biochemistry, University of Zürich, Switzerland.

                Article
                NIHMS555417
                10.1038/nature13011
                4106473
                24476820
                585f262a-58ca-4140-ac61-48139ae40e7d

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article